| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
|
Noor, Nurulamin M
|
|
|
9 |
5 |
p. 415-427
|
artikel
|
| 2 |
Addressing the evolving landscape of global malnutrition
|
The Lancet Gastroenterology & Hepatology,
|
|
|
9 |
5 |
p. 393
|
artikel
|
| 3 |
A women-focused matrix mentorship programme in gastroenterology
|
Devi, Jalpa
|
|
|
9 |
5 |
p. 405-407
|
artikel
|
| 4 |
ECCO'24
|
Gomersall, Bethany
|
|
|
9 |
5 |
p. 413
|
artikel
|
| 5 |
Effect of robotic versus open pancreaticoduodenectomy on postoperative length of hospital stay and complications for pancreatic head or periampullary tumours: a multicentre, open-label randomised controlled trial
|
Liu, Qu
|
|
|
9 |
5 |
p. 428-437
|
artikel
|
| 6 |
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics
|
Porcari, Serena
|
|
|
9 |
5 |
p. 460-475
|
artikel
|
| 7 |
Has the time come for a systematic top-down approach in Crohn's disease?
|
Fumery, Mathurin
|
|
|
9 |
5 |
p. 394-395
|
artikel
|
| 8 |
Local ablation in pancreatic cancer: some answers and more questions
|
Berman, Zachary T
|
|
|
9 |
5 |
p. 398-400
|
artikel
|
| 9 |
Microbiota therapeutics for inflammatory bowel disease: the way forward
|
Bethlehem, Lukas
|
|
|
9 |
5 |
p. 476-486
|
artikel
|
| 10 |
MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial
|
Timmer, Florentine E F
|
|
|
9 |
5 |
p. 448-459
|
artikel
|
| 11 |
NORPACT-1: implications for future trials
|
Snyder, Rebecca A
|
|
|
9 |
5 |
p. 408
|
artikel
|
| 12 |
NORPACT-1: implications for future trials – Authors' reply
|
Labori, Knut Jørgen
|
|
|
9 |
5 |
p. 408-409
|
artikel
|
| 13 |
Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial
|
van Bodegraven, Eduard A
|
|
|
9 |
5 |
p. 438-447
|
artikel
|
| 14 |
Research in Brief
|
Baker, Holly
|
|
|
9 |
5 |
p. 414
|
artikel
|
| 15 |
Robotic pancreatoduodenectomy: preparing for the future
|
Bannone, Elisa
|
|
|
9 |
5 |
p. 395-397
|
artikel
|
| 16 |
Should a no-drain policy after distal pancreatectomy become standard?
|
Klaiber, Ulla
|
|
|
9 |
5 |
p. 397-398
|
artikel
|
| 17 |
Top ten research priorities for alcohol use disorder and alcohol-related liver disease: results of a multistakeholder research priority setting partnership
|
Subhani, Mohsan
|
|
|
9 |
5 |
p. 400-402
|
artikel
|
| 18 |
Use of immunomodulators in combination with infliximab in Crohn's disease: time for a reappraisal?
|
Chapman, Thomas P
|
|
|
9 |
5 |
p. 402-405
|
artikel
|
| 19 |
US Government, states reign in insurers' prior authorisation
|
Furlow, Bryant
|
|
|
9 |
5 |
p. 411-412
|
artikel
|
| 20 |
Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake
|
Wu, Yu
|
|
|
9 |
5 |
p. 409
|
artikel
|
| 21 |
Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake – Authors' reply
|
Israelsen, Mads
|
|
|
9 |
5 |
p. 409-410
|
artikel
|
Tijdschrift beschrijving